e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Rehabilitation: more than just exercise
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Determining factors for the altered adipokine metabolism in women with COPD
E. P. A. Rutten, M. K. Breyer, N. W. Locantore, M. L. Watkins, B. E. Miller, E. F. M. Wouters (Horn, Netherlands; NC, King of Prussia, United States Of America)
Source:
Annual Congress 2010 - Rehabilitation: more than just exercise
Session:
Rehabilitation: more than just exercise
Session type:
Thematic Poster Session
Number:
621
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. P. A. Rutten, M. K. Breyer, N. W. Locantore, M. L. Watkins, B. E. Miller, E. F. M. Wouters (Horn, Netherlands; NC, King of Prussia, United States Of America). Determining factors for the altered adipokine metabolism in women with COPD. Eur Respir J 2010; 36: Suppl. 54, 621
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Features of adipokine regulation at young patients with bronchial asthma with different phenotypes of obesity
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019
Adipokines and hormones responsible for regulation of energy intake and clinical outcome in childhood asthma
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008
Prevalence of metabolic syndrome in women asthma patients: role of adipokines
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
Is OSA an important risk factor for metabolic dysregulation in obese COPD patients
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Altered lung physiology in obesity and how to intervene
Source: Annual Congress 2006 - Asthma in obesity: a new entity?
Year: 2006
Leptin levels are associated with reduced lung function in men with COPD
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
Does obesity affects circulating inflammatory cytokines in asthmatic children?
Source: Annual Congress 2009 - Epidemiology and risk factors of childhood asthma: what every clinician should know
Year: 2009
The role of leptin and adiponectin in patients with COPD
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
Adipokine mediators in asthma and COPD are affected by sex and age
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Features of carbohydrate metabolism in patients with COPD
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012
Gender related differences of circulating leptin in COPD
Source: Annual Congress 2009 - Emerging physiology behind pulmonary rehabilitation
Year: 2009
Carbohydrate metabolism state in COPD patients
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010
Plasma leptin in asthma patients with steroid induced diabetes compared with obesity patients
Source: Eur Respir J 2007; 30: Suppl. 51, 555s
Year: 2007
Serum leptin, adponectin and its tissue expression in COPD patients with osteopenic syndrome
Source: International Congress 2015 – COPD: notable points
Year: 2015
Defective metabolic adaptation in the pathogenesis of COPD
Source: International Congress 2019 – Metabolic alterations as a driver of chronicity in lung disease
Year: 2019
Metabolic consequences of obesity as an “outside in” mechanism of disease severity in asthma
Source: Eur Respir J 2016; 48: 291-293
Year: 2016
The influence of hyperinflation on body composition and cytokine profile in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
IgE-autoantibodies and adipokines in patients with bronchial asthma and obesity
Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma
Year: 2012
Fructosamine-3-Kinase: A molecular link between COPD and diabetes regulating carbonyl stress and the impact of metformin treatment
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Features of cellular structure of the induced sputum at patients of young age in sintropiya of asthma and obesity
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept